Antony Mattessich
Independent DirectorMr. Antony Mattessich was CEO & Director of Amphista Therapeutics Limited from September 2024 until March 2026. Mr. Mattessich serves as Director of Aura Biosciences, Inc. since September 2021. He had been the Chief Executive Officer and President of Ocular Therapeutix, Inc. since July 26, 2017 until April 15, 2024. Mr. Mattessich served as Managing Director of Mundipharma International Limited from May 2011 until July 2017. He served as Managing Director of Napp Pharmaceutical Group, a pharmaceutical company and an independent associated company of Mundipharma, from 2005 until January 2009. He served as Regional Director of Europe Operations at Mundipharma International Limited. He has wealth of experience to Ocular Therapeutix, having held leadership roles for a number of global pharmaceutical companies across the US, Europe and Asia, including Novartis, Bristol Meyers Squibb and Merck & Co. Over the course of his career, Mr. Mattessich has developed expertise across multiple disciplines, including general management, global marketing, new product planning, R&D and business development. He also held several positions at Bristol-Myers Squibb, among them, Managing Director roles in Malaysia/Singapore and The Netherlands and Head of Operations for the International Medicines Group. He ran the U.S. respiratory, dermatology and pediatrics group at Novartis. Prior to joining Mundipharma International, he served as Therapeutic Franchise Head of Novartis AG, a pharmaceutical company. Mr. Mattessich was the Managing Director of one of the world’s largest privately-owned pharmaceutical companies, Mundipharma. He had been a Director of Ocular Therapeutix, Inc. since June 20, 2017 until April 15, 2024. He has held several senior executive positions where he was instrumental in developing medicines that translate innovative science into meaningful clinical outcomes for patients, with extensive experience in CNS, haemato-oncology, immunology and metabolics. Mr. Mattessich holds a Masters in International Affairs from Columbia University and a B.A. from the University of California at Berkeley.
Positions
- Company NameAura Biosciences, Inc.Stock CodeAURAPositionIndependent DirectorColleagues
- JJJ. Jill HopkinsChief Medical Officer & President of Research and Development
- DMDavid Michael JohnsonIndependent Chairman of the Board
- NCNatalie C. HollesPresident, CEO & Director
- AEAmy ElazzouziSenior Vice President of Finance, Treasurer and Secretary
- SASusan Abu-AbsiChief Operating Officer
- ADAlex DasallaHead of Investor Relations & Corporate Communications
- GMGiovanni MariggiIndependent Director
- SSSapna SrivastavaIndependent Director
